It has been a mixed year for Passage BIO, Inc. insiders: $206,000 bought by one person and $113,000 sold by two, so more buying than selling overall.
The largest purchase came from Nichols Weston (10% Owner), about $206,000.
On the institutional side, 30 funds reported holding PASG at the end of Q2 2026, and more funds sold than bought. Looking at the quarterly pattern: No open-market insider buying or selling in the last full quarter. Insiders bought in 2 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Jun 29, 2026 | Nichols Weston | 10% Owner | Buy | 50,055 | $4.12 | $206K | SEC |
| Jan 12, 2026 | Chou William | CEO | Sell | 4,076 | $18.44 | $75K | SEC |
| Jan 12, 2026 | Borthwick Kathleen | CFO | Sell | 2,062 | $18.44 | $38K | SEC |
| Sep 15, 2025 | Nichols Weston | 10% Owner | Buy | 11,900 | $6.99 | $83K | SEC |
| Sep 15, 2025 | Nichols Weston | 10% Owner | Buy | 325 | $6.96 | $2K | SEC |
| Sep 15, 2025 | Nichols Weston | 10% Owner | Buy | 19,783 | $6.99 | $138K | SEC |
| Jul 24, 2025 | Lynx1 Capital Management LP | 10% Owner | Buy | 66,423 | $5.71 | $379K | SEC |
| Jul 24, 2025 | Lynx1 Capital Management LP | 10% Owner | Buy | 13,123 | $5.44 | $71K | SEC |
| Jul 24, 2025 | Lynx1 Capital Management LP | 10% Owner | Buy | 49,302 | $5.74 | $283K | SEC |
| Jun 26, 2025 | ORBIMED ADVISORS LLC | 10% Owner | Sell | 231,600 | $0.35 | $81K | SEC |
| Jun 26, 2025 | ORBIMED ADVISORS LLC | 10% Owner | Sell | 213,257 | $0.33 | $70K | SEC |
| Jun 26, 2025 | ORBIMED ADVISORS LLC | 10% Owner | Sell | 138,800 | $0.33 | $46K | SEC |
| Apr 24, 2025 | ORBIMED ADVISORS LLC | 10% Owner | Sell | 68,195 | $0.32 | $22K | SEC |
| Apr 24, 2025 | ORBIMED ADVISORS LLC | 10% Owner | Sell | 89,328 | $0.34 | $30K | SEC |
| Apr 24, 2025 | ORBIMED ADVISORS LLC | 10% Owner | Sell | 78,049 | $0.34 | $27K | SEC |
In the last 12 months Passage BIO, Inc. insiders made open-market purchases worth about $206,000 and sales worth about $113,000. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in PASG was filed on 2026-06-29.
30 investment managers reported holding PASG in SEC Form 13F filings for Q2 2026.
No congressional trades in PASG were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).